Inventor · disambiguated record
Kevin Wayne Kuntz
Also filed as: KUNTZ KEVIN · KUNTZ KEVIN W · KUNTZ KEVIN WAYNE
93 granted patents·68 pending applications·1,400 citations·filing 1999–2025
99Inventor score
Files withEPIZYME INC111RIBON THERAPEUTICS INC27BOEHRINGER INGELHEIM INT3KUNTZ KEVIN WAYNE3SMITHKLINE BEECHAM CORP3
Top patents by PatentIndex Score
161 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0399US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0499US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0599US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0698US9943504B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Apr 17, 2018·14 cites·17 claims
- 0798US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 0898US9532992B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 3, 2017·32 cites·25 claims
- 0998US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 1098US9394258B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 19, 2016·39 cites·13 claims
- 1198US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 1298US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 1397US11491163B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2020·Granted Nov 8, 2022·6 cites·10 claims
- 1497US11370781B2Combination therapy for treating cancerEPIZYME INC·Filed 2020·Granted Jun 28, 2022·4 cites·20 claims
- 1597US11014913B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Granted May 25, 2021·6 cites·13 claims
- 1697US10550105B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·13 cites·8 claims
- 1797US9765035B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 19, 2017·15 cites·14 claims
- 1897US9394283B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2013·Granted Jul 19, 2016·27 cites·25 claims
- 1997US9334527B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·39 cites·13 claims
- 2097US9089575B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jul 28, 2015·19 cites·16 claims
- 2197US9045477B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Jun 2, 2015·19 cites·17 claims
- 2297US9006242B2Substituted benzene compoundsEPIZYME INC·Filed 2013·Granted Apr 14, 2015·38 cites·18 claims
- 2397US8410088B2Aryl- or heteroaryl-substituted benzene compoundsKUNTZ KEVIN W·Filed 2012·Granted Apr 2, 2013·96 cites·25 claims
- 2496US11642348B2Substituted benzene compoundsEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·12 claims
- 2596US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 2696US10787440B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Sep 29, 2020·8 cites·20 claims
- 2796US10301290B2Combination therapy for treating cancerEPIZYME INC·Filed 2013·Granted May 28, 2019·13 cites·9 claims
- 2896US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 2996US9872862B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2016·Granted Jan 23, 2018·14 cites·17 claims
- 3096US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 3196US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 3296US9447079B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 20, 2016·38 cites·13 claims
- 3396US9175331B2Inhibitors of human EZH2, and methods of use thereofKUNTZ KEVIN WAYNE·Filed 2012·Granted Nov 3, 2015·46 cites·8 claims
- 3496US8691507B2Inhibitors of human EZH2 and methods of use thereofEPIZYME INC·Filed 2013·Granted Apr 8, 2014·40 cites·12 claims
- 3595US11566020B1Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2021·Granted Jan 31, 2023·3 cites·26 claims
- 3695US10821113B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2019·Granted Nov 3, 2020·6 cites·20 claims
- 3795US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 3895US9776996B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Oct 3, 2017·13 cites·17 claims
- 3995US9701666B21,4-pyridone bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Jul 11, 2017·14 cites·18 claims
- 4094US10870641B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·6 cites·30 claims
- 4194US10710987B2Hydrochloride salt form for EZH2 inhibitionEPIZYME INC·Filed 2018·Granted Jul 14, 2020·8 cites·25 claims
- 4294US10463671B2Combination therapy for treating cancerEPIZYME INC·Filed 2017·Granted Nov 5, 2019·12 cites·25 claims
- 4394US10273223B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
- 4494US9637472B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted May 2, 2017·16 cites·19 claims
- 4594US9333217B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·23 cites·6 claims
- 4694US9243001B2Substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jan 26, 2016·10 cites·4 claims
- 4794US8722877B27-deazapurine modulators of histone methyltransferase, and methods of use thereofEPIZYME INC·Filed 2013·Granted May 13, 2014·19 cites·12 claims
- 4894US8580762B2Substituted purine and 7-deazapurine compoundsOLHAVA EDWARD JAMES·Filed 2011·Granted Nov 12, 2013·37 cites·6 claims
- 4993US11535621B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2020·Granted Dec 27, 2022·3 cites·4 claims
- 5093US10098888B2Substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Oct 16, 2018·8 cites·16 claims
Showing the top 50 of 161 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →